Abbott pauses on deals, to focus on St. Jude integration

(Reuters) - Abbott Laboratories said it planned to focus on slashing its debt and integrating its $25 billion acquisition of St. Jude Medical in 2017, in a break from the hectic pace of dealmaking last year

Abbott pauses on deals, to focus on St. Jude integration
Read More


Bagikan Berita Ini